The Antileishmanial, Antioxidant and Cytotoxic Potential of Cecropia concolor Willd (Urticaceae), an Amazonian Species

Cecropia sp. (Urticaceae) are commonly used in traditional medicine in South American countries for the treatment of different diseases. To date, the species Cecropia concolor Willd, of Amazonian occurrence, has not been investigated for its pharmacological potential. In this study, we described the chemical profile and the antileishmanial, antioxidant and cytotoxic activities of extracts of the leaves of C. concolor. The ethanolic extract and its partition phases (hexane, ethyl acetate and hydroethanolic) were analyzed for their chemical classes and phenolic content. Antileishmanial activity was assessed against Leishmania (L.) amazonensis. The antioxidant activity was evaluated using the DPPH method and in MRC-5 human fibroblast cells. Toxicity was tested against Artemia salina and in human cells (fibroblasts and cancer lines). The leaves of C. concolor have phenolic substances, such as flavonoids, as well as terpenes, steroids and alkaloids. Chlorogenic acid, caffeic acid, schaftoside and vicenin 2 were identified. The hydroethanolic phase showed a high concentration of phenolic compounds and pronounced antioxidant activity. The antileishmanial activity was observed in the ethanolic extract, with a promising effect of the hexane phase. The C. concolor ethanolic extract and its phases are non-toxic, which makes this species of interest in pharmaceutical and cosmetics applications.